Universal Health Services Charts Growth Amid Policy Headwinds

Universal Health Services ((UHS)) has held its Q4 earnings call. Read on for the main highlights of the call.

Universal Health Services’ latest earnings call struck a confident yet measured tone, pairing double‑digit revenue and earnings growth with disciplined risk management. Executives highlighted expanding margins, a robust pipeline of new facilities, aggressive share repurchases, and early wins from AI initiatives, while openly addressing exchange headwinds, California staffing rules, and near‑term volume and cash flow pressures.

Quarter and Full-Year Financial Performance

UHS closed 2025 with strong momentum, as fourth‑quarter revenue rose 9% and adjusted EBITDA net of NCI climbed 10%, driving a 20% jump in adjusted EPS versus Q4 2024. For the full year, revenue grew 10%, adjusted EBITDA net of NCI advanced 15%, and adjusted EPS surged 31% from 2024, underscoring broad‑based operating leverage.

Strong Acute Care Operational Results

Same‑facility acute care operations delivered solid growth, with Q4 net revenue up 6.9%, or 5.2% excluding the insurance arm, and revenue per adjusted admission increasing 5.4%. Segment EBITDA rose 10.4% in the quarter as margins improved 50 bps to 14.8%, aided by contract labor falling to 2.4% of segment revenue and a 150 bps full‑year margin gain to 15.8%.

Behavioral Health Revenue and Volume Recovery

Behavioral Health continued its recovery, posting 7.2% same‑facility net revenue growth in Q4, driven by a 5.6% rise in revenue per adjusted patient day and a 1.5% increase in patient days. Segment EBITDA grew 6.9% in the quarter and 7.8% for 2025, as volumes improve but still face pockets of pressure tied to staffing constraints.

Prudent Capital Allocation and Share Repurchases

Management emphasized disciplined capital deployment, with UHS repurchasing 4.65 million shares for $899 million in 2025, including 1.46 million in Q4 alone. The company ended the year with $1.425 billion of remaining buyback authorization and roughly $900 million of revolver capacity, giving it ample flexibility for continued repurchases and growth investments.

Growth Pipeline and Outpatient Expansion

UHS is leaning into both inpatient and outpatient growth, having opened two acute hospitals over the past two years and planning three inpatient expansions totaling 178 beds plus a 156‑bed de novo facility in Palm Beach Gardens slated for Q2 2026. In Behavioral, two new hospitals adding 264 beds and an expanding outpatient footprint, including at least 20 freestanding 1,000 Branches Wellness centers across 2025–2026, are designed to capture rising demand.

Technology and AI Adoption to Improve Efficiency

The company highlighted accelerated use of AI tools to drive efficiency, including an “agentic” AI platform for post‑discharge care aimed at reducing readmissions and AI‑driven revenue cycle technology to enhance documentation and appeals. UHS is also using AI to streamline behavioral referral and intake processes, reporting measurable early gains with expectations for more margin benefits ahead.

Exchange Coverage Headwind

Management flagged health insurance exchange changes as a meaningful 2026 headwind, with guidance embedding about a $75 million pretax earnings impact. UHS assumes a 25%–30% drop in exchange volumes, of which only 10%–20% is expected to shift to other coverage, largely self‑pay or uninsured, with the pressure concentrated in the Acute Care segment.

California Behavioral Staffing Regulation Impact

New California rules for inpatient psychiatric staffing effective mid‑2026 are set to raise costs, with UHS estimating a roughly $35 million pretax hit next year and about $30 million in ongoing annual expense. The impact stems from a higher licensed nurse mix, recruiting and training needs, and potential short‑term census disruption as facilities adjust to the new requirements.

Cash Flow and Receivables Timing Pressure

Operating cash flow for the twelve months ended December 31, 2025 was $1.9 billion, down from $2.1 billion a year earlier, as timing issues weighed on reported numbers. Management cited about $50 million tied up in receivables at two new hospitals and roughly $145 million of timing‑related Medicaid supplemental payment delays, which they view as manageable rather than structural.

Behavioral Labor and Margin Pressure in Some Markets

While Behavioral volumes are recovering, labor remains a pinch point, with headcount up 3.1% in Q4 and same‑facility labor expense per adjusted day rising 7.3% in the U.S. These cost increases outpaced revenue in certain markets, limiting margin expansion and constraining volume growth where staffing availability continues to lag demand.

Near-Term Volume and Market Softness

Acute same‑facility adjusted admissions were flat in Q4, though they would have risen 1% excluding softness in Las Vegas, highlighting localized challenges. Management warned that winter storms and regional weakness, particularly in Las Vegas and Washington, D.C., are likely to push first‑quarter 2026 volumes below full‑year assumptions, even as the broader demand backdrop remains solid.

Medicaid Supplemental and Policy Uncertainties

Policy and supplemental funding remain swing factors, with guidance assuming a $1.36 billion net Medicaid supplemental benefit in 2026, up about $23 million from 2025 and including a new Nevada program. A potential Florida program worth an estimated $45–$50 million is not yet approved, and a California supplemental program remains uncertain, leaving room for material upside or downside relative to current forecasts.

Forward-Looking Guidance and Outlook

For 2026, UHS guided revenue to $18.4–$18.8 billion, implying 6%–8% growth, adjusted EBITDA net of NCI of $2.64–$2.79 billion, and adjusted EPS of $22.64–$24.52, up 4%–13%. The outlook assumes 2%–3% volume growth per segment, pricing tailwinds, about 5% core organic growth, capex of $950 million–$1.1 billion as major projects come online, and explicitly bakes in exchange and California staffing headwinds along with modest benefits from Medicaid and operational improvements.

UHS’s earnings call painted a picture of a company using solid volume trends, expanding margins, and targeted AI and capacity investments to offset policy and payer headwinds. For investors, the story blends clear near‑term challenges with a credible plan for continued growth, disciplined capital returns, and potential upside from regulatory outcomes and operational execution.